Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group

Assessment of minimal residual disease has emerged as a powerful prognostic factor in acute myeloid leukemia. In this study, we investigated the potential of IDH1/2 mutations as targets for minimal residual disease assessment in acute myeloid leukemia, since these mutations collectively occur in 15–...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferret, Yann, Boissel, Nicolas, Helevaut, Nathalie, Madic, Jordan, Nibourel, Olivier, Marceau-Renaut, Alice, Bucci, Maxime, Geffroy, Sandrine, Celli-Lebras, Karine, Castaigne, Sylvie, Thomas, Xavier, Terré, Christine, Dombret, Hervé, Preudhomme, Claude, Renneville, Aline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927984/
https://www.ncbi.nlm.nih.gov/pubmed/29472349
http://dx.doi.org/10.3324/haematol.2017.183525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927984/
https://www.ncbi.nlm.nih.gov/pubmed/29472349
http://dx.doi.org/10.3324/haematol.2017.183525

Ejemplares similares